RICTOR/mTORC2 affects tumorigenesis and therapeutic efficacy of mTOR inhibitors in esophageal squamous cell carcinoma
Dysregulation of mTORC1/mTORC2 pathway is observed in many cancers and mTORC1 inhibitors have been used clinically in many tumor types; however, the mechanism of mTORC2 in tumorigenesis is still obscure. Here, we mainly explored the potential role of mTORC2 in esophageal squamous cell carcinoma (ESC...
Saved in:
Main Authors: | Zhaoming Lu (Author), Xiaojing Shi (Author), Fanghua Gong (Author), Shenglei Li (Author), Yang Wang (Author), Yandan Ren (Author), Mengyin Zhang (Author), Bin Yu (Author), Yan Li (Author), Wen Zhao (Author), Jianying Zhang (Author), Guiqin Hou (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
mTORC1 and mTORC2 Levels in Patients With Psoriasis
by: İlayda Esna Gülsunay, et al.
Published: (2024) -
mTOR hyperactivity and RICTOR amplification as targets for personalized treatments in malignancies
by: Dániel Sztankovics, et al.
Published: (2024) -
mTORC1 signaling pathway regulates tooth repair
by: Honghong Liu, et al.
Published: (2023) -
Regulation of bone formation by baicalein via the mTORC1 pathway
by: Li SF, et al.
Published: (2015) -
OTUD3 suppresses the mTORC1 signaling by deubiquitinating KPTN
by: Jiatao Li, et al.
Published: (2024)